Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2026-01-02 @ 8:32 PM
Study NCT ID:
NCT03442569
Status:
COMPLETED
Last Update Posted:
2025-07-01
First Post:
2018-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
Sponsor:
Organization: